CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND VRTX Holdings History
CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND's Vertex Pharmaceuticals Inc Holding Summary
As of 2025-03-31, CITY NATIONAL ROCHDALE FUNDS held 12,196.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $5.91 Mil. This investment constitutes 1.7% of their stock portfolio, and CITY NATIONAL ROCHDALE FUNDS now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.
The initial trade took place in 2022Q4. And since then CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND has made 3 purchases of VRTX, at an average price of $335.85, for a total of 19,000.00 shares. In addition, there have been 1 sales at an average price of $463.43 for 6,804.00 shares. Based on historical transaction data and VRTX's current price of $459.81, CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND's estimated gain on his VRTX holdings is $2.38 Mil, reflecting a 37.30% gain to date.
CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND VRTX ($459.81) Holding Chart
CITY NATIONAL ROCHDALE U.S. CORE EQUITY FUND VRTX ($459.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
